Gold Mecal Sinitsyn

Feb 27, 2019
Latest in Clinical News
Image2
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
June 26, 2026
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
Novel SST2-PET tracer shows promise in patients with NETs
June 25, 2026
Prof. Nathalie Albert of Ludwig Maximilian University of Munich, member of the EANM Oncology & Theranostics Committee and Scientific Chair of the NMN Symposium.
PET RANO gains visibility as neurotheranostics research advances
June 24, 2026
Prof. Clemens Decristoforo is a member of the EANM Policy & Regulatory Affairs Council and professor at the Department of Nuclear Medicine at the Medical University of Innsbruck.
As theranostics advances, access challenges remain across Europe
June 24, 2026
Related Stories
2019 02 27 00 52 1962 2019 02 27 Philips Azurion 20190227004112
Conference
Digital x-ray vendors focus on workflow and efficiency
2019 02 26 23 56 2519 2019 02 27 Nh 1 Cest Thumb
Conference
Liquid biopsy can be game-changer in radiology
2019 02 26 21 00 5734 2019 02 27 Ecr Today Hybrid Thumb
Conference
Be aware of artifacts to improve hybrid imaging outcomes
2019 02 26 21 41 8471 Ecr 2019 400
Conference
AI enables real-time patient dose estimates on CT exams
More in Clinical News
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
By AuntMinnieEurope.com staff writers
Imaging focuses on the mid-trimester anomaly scan.
June 26, 2026
Image2
Novel SST2-PET tracer shows promise in patients with NETs
By Will Morton
With a half-life of 3.3 hours, cyclotron-produced Cu-61 NODAGA-LM3 could allow delayed imaging and centralized distribution.
June 25, 2026
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
PET RANO gains visibility as neurotheranostics research advances
By Claudia Tschabuschnig
Standardized PET response assessment, emerging theranostic targets, and new strategies to overcome the blood-brain barrier are among the developments shaping neuro-oncology research.
June 24, 2026
Prof. Nathalie Albert of Ludwig Maximilian University of Munich, member of the EANM Oncology & Theranostics Committee and Scientific Chair of the NMN Symposium.
As theranostics advances, access challenges remain across Europe
By Claudia Tschabuschnig
Theranostics is advancing rapidly, but access remains uneven across Europe. According to Prof. Clemens Decristoforo, differences in national regulations and healthcare systems continue to influence patient access to innovative radiopharmaceuticals.
June 24, 2026
Prof. Clemens Decristoforo is a member of the EANM Policy & Regulatory Affairs Council and professor at the Department of Nuclear Medicine at the Medical University of Innsbruck.
BrightHeart receives CE mark for prenatal ultrasound AI platform
By AuntMinnieEurope.com staff writers
The CE mark follows an €11 million series A funding round.
June 24, 2026
Ai2
Six European societies launch RLT Referral Pathways Project
By Claudia Tschabuschnig
Radioligand therapy has proven itself clinically for advanced prostate cancer. What hasn't caught up is Europe's healthcare infrastructure.
June 23, 2026
Radiology and nuclear medicine are converging on clinical audit and quality frameworks across Europe.
DRGEM wins CE certification for mobile DR system
By AuntMinnie.com staff writers
The certification follows U.S. Food and Drug Administration clearance for Raymo in May.
June 22, 2026
Approval
$9M grant invests in 'next generation' of CAA scientists
By AuntMinnie.com staff writers
Project will combine advanced brain imaging with new molecular biomarkers and innovative experimental models.
June 19, 2026
Dollars Pile
PET/CT could improve margin assessment for breast tumors
By Amerigo Allegretto
Specimen PET/CT imaging outperforms routine intraoperative margin assessment in breast tumors.
June 19, 2026
Pet Scan Patient 400 (1)
Single-fraction SBRT a valid option for localized prostate cancer
By Will Morton
Estimated three-year biochemical relapse-free survival was 92.9%.
June 18, 2026
Prostate Imaging
Canon unveils Aplio me X ultrasound system at Euroson 2026
By AuntMinnieEurope.com staff writers
Canon Medical Systems unveiled its Aplio me X diagnostic ultrasound system at Euroson 2026.
June 18, 2026
Aplio me X ultrasound system
WHO: Europe's healthcare systems face "permacrisis"
By Claudia Tschabuschnig
Overlapping shortages, an aging population, and a workforce "voting with its feet" -- "permacrisis," that's how WHO Europe described the state of healthcare on the continent at the inaugural UEMS Congress in Leuven.
June 18, 2026
'We are no longer preparing for crises. We are actively navigating an era of permanent, overlapping disruptions, the convergence of rapid climate change, demographic shifts, systemic economic uncertainty, and a critical healthcare workforce means that traditional boundaries of healthcare are obsolete,' says Pavlos Theodorakis, senior health policy advisor at the WHO European Office.
Page 1 of 1325
Next Page